ロード中...
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
Attenuating postprandial hyperglycaemia is a critical factor in the achievement of optimal glucose control. Prandial insulin analogues have been developed to replicate the physiology of normal endogenous insulin secretion and action, with the aim of limiting postprandial glucose excursions. There is...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6778592/ https://ncbi.nlm.nih.gov/pubmed/31485918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00685-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|